| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.61 | 0.004 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.22 | 0.006 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |